<p>Random effect model of odds ratio for recurrence of follow-up 1 (A), 3 (B), 5-year (C) of CRC patients after surgery: high FoxP3<sup>+</sup> T cells infiltration patients <i>vs</i> low FoxP3<sup>+</sup> T cells infiltration patients.</p
<p>(A) Co-clustering matrix of CRC samples generated by NBS analysis. The matrix color intensity rep...
<p>Number of CSCs at the end of the recurrence tumor stage (where about 10<sup>6</sup> cells is agai...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
<p>Fixed effect model of odds ratio for survival of follow-up 1 (A), 3 (B), 5-year (C) of CRC patien...
<p>Fixed effect model of odds ratio for recurrence of follow-up 1(A), 5-year (C) and random effect m...
<p>Random effect model of odds ratio for survival of follow-up 1 (A), 3 (B), 5-year (C) of GC patien...
<p>Fixed effect model of odds ratio for survival of follow-up 1(A), 3-year (B) and random effect mod...
Purpose: This population-based study determined the cumulative incidence (CI) of local, regional, an...
The host's immune response is very important in slowing the progression of the disease in solid canc...
<p>Each risk factor was adjusted for all other risk factors listed in the table.</p><p><sup>a</sup>W...
<p>The cumulative recurrence rates were significantly different in the 4 subgroups during the 5-year...
Item does not contain fulltextPURPOSE: This population-based study determined the cumulative inciden...
<p>A) The percentage of CD4<sup>+</sup>cFOXP3<sup>+</sup>cells was plotted against the percentage of...
Results of the logistic regression analysis of cytokines between CRC patients and controls after adj...
<p>(A) <i>Total</i>, probability of survival of all patients with CRC: low intratumoral neutrophil, ...
<p>(A) Co-clustering matrix of CRC samples generated by NBS analysis. The matrix color intensity rep...
<p>Number of CSCs at the end of the recurrence tumor stage (where about 10<sup>6</sup> cells is agai...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
<p>Fixed effect model of odds ratio for survival of follow-up 1 (A), 3 (B), 5-year (C) of CRC patien...
<p>Fixed effect model of odds ratio for recurrence of follow-up 1(A), 5-year (C) and random effect m...
<p>Random effect model of odds ratio for survival of follow-up 1 (A), 3 (B), 5-year (C) of GC patien...
<p>Fixed effect model of odds ratio for survival of follow-up 1(A), 3-year (B) and random effect mod...
Purpose: This population-based study determined the cumulative incidence (CI) of local, regional, an...
The host's immune response is very important in slowing the progression of the disease in solid canc...
<p>Each risk factor was adjusted for all other risk factors listed in the table.</p><p><sup>a</sup>W...
<p>The cumulative recurrence rates were significantly different in the 4 subgroups during the 5-year...
Item does not contain fulltextPURPOSE: This population-based study determined the cumulative inciden...
<p>A) The percentage of CD4<sup>+</sup>cFOXP3<sup>+</sup>cells was plotted against the percentage of...
Results of the logistic regression analysis of cytokines between CRC patients and controls after adj...
<p>(A) <i>Total</i>, probability of survival of all patients with CRC: low intratumoral neutrophil, ...
<p>(A) Co-clustering matrix of CRC samples generated by NBS analysis. The matrix color intensity rep...
<p>Number of CSCs at the end of the recurrence tumor stage (where about 10<sup>6</sup> cells is agai...
Objectives To assess the prognostic impact of time to recurrence (TTR) on cancer-specific survival (...
DOI
Add to ORKG